Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation
暂无分享,去创建一个
D. Capper | C. Hartmann | A. Deimling | C. Herold-Mende | T. Gaiser | W. Mueller | M. Siegelin | A. Habel | C. Herold‐Mende | A. Deimling
[1] O. Wiestler,et al. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins , 2008, Oncogene.
[2] S. Fulda,et al. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. , 2008, Cancer research.
[3] J. Neuzil,et al. CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP. , 2008, Biochemical and biophysical research communications.
[4] R. Herbst,et al. To kill a tumor cell: the potential of proapoptotic receptor agonists. , 2008, The Journal of clinical investigation.
[5] V. Puduvalli,et al. Bortezomib Sensitizes Human Astrocytoma Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis , 2007, Clinical Cancer Research.
[6] J. Meixensberger,et al. Bortezomib Sensitizes Primary Human Astrocytoma Cells of WHO Grades I to IV for Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis , 2007, Clinical Cancer Research.
[7] Gabriele Schackert,et al. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. , 2007, Carcinogenesis.
[8] F. Khuri,et al. The farnesyltransferase inhibitor R115777 up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer cells. , 2007, Cancer research.
[9] F. Khuri,et al. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. , 2007, Cancer research.
[10] S. Fulda,et al. Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells , 2007, Oncogene.
[11] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[12] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[13] K. Black,et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.
[14] S. Fulda,et al. 5-Aza-2′-deoxycytidine and IFN-γ cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8 , 2006, Oncogene.
[15] S. Fulda,et al. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy , 2006, Oncogene.
[16] Michael Weller,et al. Changing paradigms--an update on the multidisciplinary management of malignant glioma. , 2006, The oncologist.
[17] L. Ricci-Vitiani,et al. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction. , 2005, Cancer research.
[18] N. Maitland,et al. Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.
[19] Seung U. Kim,et al. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP , 2005, Oncogene.
[20] A. Kaye,et al. Caspase 8 is absent or low in many ex vivo gliomas , 2005, Cancer.
[21] Li Yu,et al. [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.
[22] A. von Deimling,et al. Molecular Genetic Analysis of Oligodendroglial Tumors , 2005, Journal of neuropathology and experimental neurology.
[23] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[24] L. Ricci-Vitiani,et al. Absence of Caspase 8 and High Expression of PED Protect Primitive Neural Cells from Cell Death , 2004, The Journal of experimental medicine.
[25] P. Dirks,et al. Cancer stem cells in nervous system tumors , 2004, Oncogene.
[26] Eun Hee Kim,et al. Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP , 2004, Oncogene.
[27] A. Ashkenazi,et al. Apo2L/TRAIL and its death and decoy receptors , 2003, Cell Death and Differentiation.
[28] F. Beguinot,et al. Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma Cells* , 2002, The Journal of Biological Chemistry.
[29] S. Fulda,et al. IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway , 2002, Oncogene.
[30] Yahong Lin,et al. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. , 2002, Genes & development.
[31] Michael Weller,et al. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo , 2002, Nature Medicine.
[32] Erwin G. Van Meir,et al. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. , 2001, Cancer research.
[33] J. Bodmer,et al. Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis. , 2000, Medical and pediatric oncology.
[34] J. Tschopp,et al. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. , 2000, Cancer research.
[35] F. Behm,et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.
[36] J. Herman,et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.
[37] M. Peter,et al. FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* , 1997, The Journal of Biological Chemistry.
[38] Margot Thome,et al. Inhibition of death receptor signals by cellular FLIP , 1997, Nature.
[39] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] David Wallach,et al. Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.
[41] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.